Decitabine

Decitabine is used in the treatment of myelodysplastic syndrome and blood cancer.

Decitabine interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.

Nausea, Vomiting, Headache, Fever, Decreased white blood cell count (neutrophils), Anemia (low number of red blood cells), Low blood platelets, Diarrhea, Pneumonia, Stomatitis (Inflammation of the mouth), Febrile neutropenia, Decreased white blood cell count (lymphocytes), Swelling of lymph nodes, Thrombocythemia, Pulmonary edema, Blurred vision, Constipation, Abdominal pain, Dyspepsia, Ascites (accumulation of fluid in the abdominal cavity), Piles, Tongue ulcer, Difficulty in swallowing, Upper abdominal pain, Gastro-esophageal reflux disease, Peripheral edema, Rigors, Edema (swelling), Pain, Catheter site pain, Injection site swelling, Increased bilirubin in the blood, Cellulitis, Fungal infection, Urinary tract infection, Fungal infection of mouth, Transfusion reaction, Heart murmur, Increased alkaline phosphatase level in blood, Increased aspartate aminotransferase, Increased blood urea, Increased lactate dehydrogenase level in blood, Increased glucose level in blood, Low albumin level in blood, Decreased magnesium level in blood, Decreased potassium level in blood, Decreased sodium level in blood, Increased potassium level in blood, Joint pain, Insomnia (difficulty in sleeping), Confusion, Pharyngitis, Hypoxia (decreased oxygen level in blood), Cough, Ecchymosis (discoloration of the skin resulting from bleeding underneath), Petechiae (red or purple spot caused by bleeding into the skin)